Intervention not reported
Overall five year survival ‐ Colon cancer · Patients with outcomes after colorectal cancer surgery
The intervention may leads to lower overall five year survival ‐ Colon cancer (low certainty).
1 finding from 1 review
Intervention not reported
Overall five year survival ‐ Colon cancer · Patients with outcomes after colorectal cancer surgery
It is very uncertain whether the intervention changes overall five year survival ‐ Colon cancer (very low certainty).
1 finding from 1 review
Intervention not reported
Overall five year survival ‐ Rectal cancer · Patients with outcomes after colorectal cancer surgery
The intervention showed no clear difference in overall five year survival ‐ Rectal cancer (low certainty).
1 finding from 1 review
Intervention not reported
Overall five year survival ‐ Rectal cancer · Patients with outcomes after colorectal cancer surgery
The intervention may leads to lower overall five year survival ‐ Rectal cancer (low certainty).
1 finding from 1 review
Intervention not reported
Overall five year survival ‐ Colorectal cancer · Patients with outcomes after colorectal cancer surgery
It is very uncertain whether the intervention changes overall five year survival ‐ Colorectal cancer (very low certainty).
1 finding from 1 review
Intervention not reported
Overall five year survival ‐ Colorectal cancer · Patients with outcomes after colorectal cancer surgery
The intervention may leads to lower overall five year survival ‐ Colorectal cancer (low certainty).
1 finding from 1 review
Intervention not reported
Overall five year survival ‐ Colorectal cancer · Patients with outcomes after colorectal cancer surgery
The intervention may leads to lower overall five year survival ‐ Colorectal cancer (low certainty).
1 finding from 1 review
Overall survival (3 years) · people with resectable stage II and III rectal cancer undergoing preoperative chemoradiation followed by surgery
It is very uncertain whether combination chemotherapy changes overall survival (3 years) compared with single‐agent chemotherapy (very low certainty).
1 finding from 1 review